167 related articles for article (PubMed ID: 24833882)
1. Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.
Zeng QL; Feng GH; Zhang JY; Chen Y; Yang B; Huang HH; Zhang XX; Zhang Z; Wang FS
World J Gastroenterol; 2014 May; 20(18):5519-26. PubMed ID: 24833882
[TBL] [Abstract][Full Text] [Related]
2. Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
Huang JF; Huang CF; Yu ML; Dai CY; Huang CI; Yeh ML; Hsieh MH; Yang JF; Hsieh MY; Lin ZY; Chen SC; Chuang WL
J Gastroenterol Hepatol; 2011 Mar; 26(3):530-5. PubMed ID: 21332548
[TBL] [Abstract][Full Text] [Related]
3. Rate and factors affecting treatment uptake of patients with chronic hepatitis C in a tertiary referral hospital.
Yan KK; Wong GL; Wong VW; Chan HL
Dig Dis Sci; 2010 Dec; 55(12):3541-7. PubMed ID: 20927593
[TBL] [Abstract][Full Text] [Related]
4. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
[TBL] [Abstract][Full Text] [Related]
6. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.
Nanba S; Ikeda F; Baba N; Takaguchi K; Senoh T; Nagano T; Seki H; Takeuchi Y; Moritou Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
J Clin Pathol; 2016 Mar; 69(3):226-33. PubMed ID: 26290259
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.
Li X; Xu H; Gao Y; Pan M; Wang L; Gao P
Medicine (Baltimore); 2017 Mar; 96(13):e6508. PubMed ID: 28353605
[TBL] [Abstract][Full Text] [Related]
8. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
[TBL] [Abstract][Full Text] [Related]
9. Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.
Li X; Wang Z; Wang L; Pan M; Gao P
Medicine (Baltimore); 2017 Jun; 96(26):e7427. PubMed ID: 28658178
[TBL] [Abstract][Full Text] [Related]
10. Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.
Moon C; Jung KS; Kim DY; Baatarkhuu O; Park JY; Kim BK; Kim SU; Ahn SH; Han KH
Dig Dis Sci; 2015 Feb; 60(2):573-81. PubMed ID: 25236421
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
Li X; Gao Y; Xu H; Hou J; Gao P
Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
Cordero-Ruiz P; Carmona-Soria I; Rodríguez-Téllez M; Caunedo-Alvarez A; Quezada-Pacheco RH; Flores-Cucho A; Romero-Gómez M; Vilches-Arenas Á
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):792-799. PubMed ID: 28445251
[TBL] [Abstract][Full Text] [Related]
13. Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Morgan TR; Ghany MG; Kim HY; Snow KK; Shiffman ML; De Santo JL; Lee WM; Di Bisceglie AM; Bonkovsky HL; Dienstag JL; Morishima C; Lindsay KL; Lok AS;
Hepatology; 2010 Sep; 52(3):833-44. PubMed ID: 20564351
[TBL] [Abstract][Full Text] [Related]
14. Impact of diabetes mellitus and hepatitis B virus coinfection on patients with chronic hepatitis C: A territory-wide cohort study.
Subramaniam S; Wong VW; Tse YK; Yip TC; Chan HL; Wong GL
J Gastroenterol Hepatol; 2018 Apr; 33(4):934-941. PubMed ID: 28949045
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of unfavorable prognosis of chronic hepatitis C.
Shchanitcyna SE; Burnevich EZ; Nikulkina EN; Filatova AL; Мoiseev SV; Мukhin NA
Ter Arkh; 2019 Mar; 91(2):59-66. PubMed ID: 31094173
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ; Weideman R; Crook T; Brown G
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):181-6. PubMed ID: 26566061
[TBL] [Abstract][Full Text] [Related]
17. Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients.
Mei R; Chi X; Wu R; Xu H; Wang X; Gao X; Sun H; Lv J; Yu G; Kong F; Jiang J; Sun B; Zhong J; Pan Y; Niu J
J Gastroenterol Hepatol; 2016 Aug; 31(8):1489-97. PubMed ID: 26750805
[TBL] [Abstract][Full Text] [Related]
18. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
19. The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.
Zheng YX; Zhou PC; Zhou RR; Fan XG
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):759-766. PubMed ID: 28240613
[TBL] [Abstract][Full Text] [Related]
20. High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study.
Berden FA; van Zwietering IM; Maan R; de Knegt RJ; Kievit W; Drenth JP
J Gastrointestin Liver Dis; 2016 Jun; 25(2):197-204. PubMed ID: 27308651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
